Hospitalist Doctors in American Fork, UT Accepting Medicare

3 Hospitalist doctors found. Showing 1 - 3

Brian J Larson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310

Marlan L Hansen, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1159 E 200 N, Suite 150, American Fork, UT 84003 Phone: 801-855-2900

Nicholas Holdaway Bishop, MD, PHD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310

News Archive

U.S. Patent Office issues Notices of Allowance covering PLC Systems's RenalGuard technology

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported that the U.S. Patent and Trademark Office had issued Notices of Allowance for two of PLC's patent applications associated with its RenalGuard® technology.

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

Study finds sharp increase in CT scan use in ED between 1996-2007

A review of national data from 1996 through 2007 reveals a sharp uptick in the use of computed tomography, or CT, scans to diagnose illnesses in emergency departments, a University of Michigan Health System study finds.

Mount Sinai scientists identify cancer's Achilles heel

Scientists at Mount Sinai School of Medicine have discovered a subpopulation of cells that display cancer stem cell properties and resistance to chemotherapy, and participate in tumor progression. This breakthrough could lead to the development of new tests for early cancer diagnosis, prognostic tests, and innovative therapeutic strategies, as reported in Cancer Cell.

Ocrelizumab drug holds promise for multiple sclerosis

An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.

Read more Medical News

› Verified 8 days ago